Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
TECENTRIQ (Atezolizumab) is an Fc-engineered, humanized, monoclonal antibody that binds to PD-L1 and blocks interactions with the PD-1 and B7.1 receptors. Atezolizumab is a non-glycosylated IgG1 kappa immunoglobulin that has a calculated molecular mass of 145 kDa.
Atezolizumab is supplied at a concentration of 60 mg/mL as a sterile, preservative-free, colorless to slightly yellow solution, which contains 16.5 mg/ mL glacial acetic acid, 62 mg/mL L-histidine, 821.6 mg/mL sucrose, 8 mg/mL polysorbate 20, pH 5.8.
Properties
Name | Atezolizumab |
CAS NO. | 1380723-44-3 |
Type | Whole antibody |
Source | Humanized |
Target | PD-L1 |
Clone | Monoclone |
Molecular Weight | 145 kDa |
Formula | C6446H9902N1706O1998S42 |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China(Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Atezolizumab
